+1 Recommend
2 collections
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation


      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Recently, myocarditis following messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccination has become an important social issue worldwide. According to the reports so far, myocarditis related to mRNA COVID-19 vaccination is rare and usually associated with a benign clinical course without intensive care or any sequelae of fulminant myocarditis. Here, we report a case of acute fulminant myocarditis and cardiogenic shock after the mRNA COVID-19 vaccination, requiring extracorporeal cardiopulmonary resuscitation. Clinicians should keep in mind the possibility of progression to fulminant myocarditis in patients who presented with suggestive symptoms or signs of myocarditis after the COVID-19 vaccination.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: found

          Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

          In this position statement of the ESC Working Group on Myocardial and Pericardial Diseases an expert consensus group reviews the current knowledge on clinical presentation, diagnosis and treatment of myocarditis, and proposes new diagnostic criteria for clinically suspected myocarditis and its distinct biopsy-proven pathogenetic forms. The aims are to bridge the gap between clinical and tissue-based diagnosis, to improve management and provide a common reference point for future registries and multicentre randomised controlled trials of aetiology-driven treatment in inflammatory heart muscle disease.
            • Record: found
            • Abstract: found
            • Article: not found

            Myocarditis With COVID-19 mRNA Vaccines

            Supplemental Digital Content is available in the text.
              • Record: found
              • Abstract: not found
              • Article: not found

              Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military


                Author and article information

                Front Cardiovasc Med
                Front Cardiovasc Med
                Front. Cardiovasc. Med.
                Frontiers in Cardiovascular Medicine
                Frontiers Media S.A.
                29 October 2021
                29 October 2021
                : 8
                [1] 1Department of Cardiovascular Medicine, Chonnam National University Medical School/Hospital , Gwangju, South Korea
                [2] 2Department of Cardiothoracic Surgery, Chonnam National University Medical School/Hospital , Gwangju, South Korea
                [3] 3Department of Emergent Medicine, Chonnam National University Hospital , Gwangju, South Korea
                [4] 4Department of Pathology, Chonnam National University Medical School , Gwangju, South Korea
                [5] 5Department of Radiology, Chonnam National University Hospital , Gwangju, South Korea
                Author notes

                Edited by: Hendrik Tevaearai Stahel, Bern University Hospital, Switzerland

                Reviewed by: Suguru Ohira, Westchester Medical Center, United States; Alberto Palazzuoli, University of Siena, Italy

                This article was submitted to Heart Failure and Transplantation, a section of the journal Frontiers in Cardiovascular Medicine

                †These authors have contributed equally to this work and share first authorship

                Copyright © 2021 Lim, Kim, Kim, Jeong, Cho, Choi and Lee.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                Page count
                Figures: 4, Tables: 0, Equations: 0, References: 24, Pages: 6, Words: 3486
                Cardiovascular Medicine
                Case Report


                Comment on this article